# A Study of Ranolazine in ALS

> **NCT06527222** · PHASE2 · RECRUITING · sponsor: **Swathy Chandrashekhar, MBBS** · enrollment: 72 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06527222
- **Lead sponsor:** Swathy Chandrashekhar, MBBS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-29
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06527222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06527222, "A Study of Ranolazine in ALS". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06527222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*